5 Top Performing Canadian IPOs of 2017

The Canadian IPOs on our list were top performing stocks after going public in 2017

SmallCapPower | January 5, 2018: Price Waterhouse Cooper publishes a quarterly survey on IPOs in Canada. Over the past year, IPOs have generated $5.1 billion in proceeds, an incredible improvement over 2016’s weak performance. Today we have identified some of the smaller Canadian IPOs that have generated significant returns to-date.

MedReleaf Corp. (TSX:LEAF) – $26.92

MedReleaf is a Licensed Producer of medical marijuana under the ACMPR. With a focus on R&D, MedReleaf aims to provide high-quality products for its patients. The Company operates two facilities in Ontario, which comprise a total 265,000 square feet.

On December 21, MedReleaf signed an agreement for the supply of medical cannabis with Shoppers Drug Mart.

  • Market Cap: $2,547.4 million
  • Return since IPO: 263.8%
  • Average Price Target: $20.21

ERO Copper Corp. (TSX:ERO) – $8.00

ERO Copper is a Canada-based mining company operating in Brazil. The Company owns and operates two mines. ERO’s Vale de Cura property produces gold and silver by-products.

  • Market Cap: $595.3 million
  • Return since IPO: 68.4%
  • Average Price Target: $8.18

Jamieson Wellness Inc. (TSX:JWEL) – $22.13

Jamieson Wellness is a Canada-based health and wellness company, which develops and manufactures vitamins and natural health products. The Company operates several different lines of branded products. JWEL’s Jamieson line is Canada’s largest consumer health brand by sales.

  • Market Cap: $833.1 million
  • Return since IPO: 28.9%
  • Average Price Target: $22.69

Fairfax Africa Holdings Corp. (TSX:FAH.U) – $17.51

Fairfax Africa Holdings is a Canada-based investment holding company. The Company invests in African businesses through equity securities and debt instruments. The Company is also engaged in insurance and investment management through its subsidiaries.

  • Market Cap: $361.1 million
  • Return since IPO: 43.6%
  • Average Price Target: N/A

Akumin Inc. (TSX:AKU.U) – $5.94

Akumin is a US-based company, which provides diagnostic imaging services in the United States. The Company operates 70 centers across multiple states. It provides a wide variety of imaging procedures.

  • Market Cap: $304.3 million
  • Return since IPO: 25.9%
  • Average Price Target: $5.50

Disclosure: Neither the author nor his/her family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: